|Position||Trades||Duration||Win rate||Win/loss||Avg win||Avg loss||Return|
|Position||Trades||Duration||Win Rate||Win/Loss||Avg Win||Avg Loss||Return|
DAILY VOLUME INDEX
Trading: SELL @ $0.16
Signal Strength: MEDIUM
Impedimed (ASX:IPD) current distribution has given weakness to the share price and the continuation of bearish trading conditions. Currently, the DVI is -18231.
Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading exit. Indicator can be applied to the short/medium term timeframe, but the best results are obtained with larger cyclical swings in-line with the trend direction. This accumulation / distribution oscillator can provide guidance on the money flow direction from the companies recent trading.
The daily volume index (DVI) is the amount of individual securities traded in a day on average over a specified period of time. Trading activity relates to the liquidity of a security. When average daily trading volume is high the stock can be easily traded and has high liquidity if trading volume is not very high and the security will tend to be less expensive because people are not as willing to buy it. As a result average daily trading volume can have an effect on the price of the security.
Calculation: Daily Volume Index (DVI):
1) [Close]-[Average price] / [Average price] x [Volume];
PROFILE: Impedimed (IPD.AX)
Stock Exchange: ASX
Ticker Codes: | IPD.AX | ASX:IPD |
ImpediMed Limited, together with its subsidiaries, engages in the development, manufacture, and sale of bioimpedance devices and consumables in Australia, North America, Europe, and internationally. The company operates through Medical and Test & Measurement segments. It offers L-Dex U400, a technology that utilizes the characteristics of frequency dependent current flow to quantify changes in extracellular fluid in the patient's limb; and SFB7, a tetra polar bioimpedance spectroscopy device that scans various frequencies for the estimation of body composition in healthy individuals. The company also provides DF50, a single frequency body composition analysis in healthy individuals; and ImpediVET, a bioimpedance spectroscopy technology for use in veterinary applications. Its products are used in a range of applications, such as in the assessment and monitoring of secondary lymphedema, as well as monitoring of body composition and hydration. In addition, the company is involved in the supply of power precision testing and measuring equipment. ImpediMed Limited was founded in 1999 and is headquartered in Pinkenba, Australia.
|OCL Objective Corporation||6.49||10||35,078||-72||BEARISH|
|MCY Mighty River Power||5||7.1||7,917||-22||BEARISH|
|RCT Reef Casino||2.62||6.9||38,587||-14||BEARISH|
|LNG Liquefied Natural Gas||0.21||5.1||2,729,105||-53,238||BEARISH|
|EDE Eden Energy||0.05||4.7||122,280||-30,277||BEARISH|
|GGG Greenland Minerals||0.13||4||2,348,815||-17,912||BEARISH|
|GTN GTN Resources||0.7||3.7||7,121||-4,308||BEARISH|
|PNR Pacific Niugini Minerals||0.14||3.7||2,478,287||-3,450||BEARISH|
|PGC Paragon Care||0.45||3.5||206,495||-5,231||BEARISH|